Jennison Associates LLC Nuvasive Inc Transaction History

Jennison Associates LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	SELL	$46.84 - $59.75 $15.2 Million - $19.3 Million	-323,556 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$48.09 - $57.79 $204,959 - $246,300	-4,262 Reduced 1.3%	323,556 $18.3 Million
Q4 2021 Feb 08, 2022	SELL	$47.19 - $62.68 $302,676 - $402,029	-6,414 Reduced 1.92%	327,818 $17.2 Million
Q2 2021 Aug 12, 2021	SELL	$64.02 - $71.72 $24.9 Million - $27.9 Million	-389,672 Reduced 53.83%	334,232 $22.7 Million
Q1 2021 May 11, 2021	BUY	$53.26 - $68.08 $38.6 Million - $49.3 Million	723,904 New	723,904 $47.5 Million
Q1 2019 May 10, 2019	SELL	$44.53 - $58.9 $10.1 Million - $13.4 Million	-227,230 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$47.64 - $71.26 $190,131 - $284,398	3,991 Added 1.79%	227,230 $11.3 Million
Q3 2018 Nov 08, 2018	BUY	$52.03 - $71.41 $208 - $285	4 Added 0.0%	223,239 $15.8 Million
Q2 2018 Aug 02, 2018	BUY	$48.15 - $56.68 $731,735 - $861,365	15,197 Added 7.3%	223,235 $11.6 Million
Q1 2018 Apr 20, 2018	BUY	$46.03 - $61.28 $1.48 Million - $1.96 Million	32,060 Added 18.22%	208,038 $10.9 Million
Q4 2017 Jan 25, 2018	SELL	$50.58 - $60.79 $192,254 - $231,062	-3,801 Reduced 2.11%	175,978 $10.3 Million
Q3 2017 Nov 03, 2017	BUY	$53.54 - $68.0 $9.63 Million - $12.2 Million	179,779	179,779 $9.97 Million

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.